The contribution of the acquired Icagen assets and business to Ligand is currently expected to increase in 2021, with revenues of approximately $12 million and adjusted earnings per diluted share ICAgen has 4 employees across 2 locations, $6.1 m in total funding, and $13.58 m in annual revenue in FY 2018. See insights on ICAgen including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Durham, NC HQ. United States Icagen's extensive biological capability focused on ion channels, transporters and x-ray fluorescence, along with a strong track record in novel drug discovery from screening to lead optimization. Icagen - Core Assets, Partnered Programs And ION Channel Technologies is located in Durham, North Carolina, United States. Who are Icagen SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the completion of its acquisition of the core assets of Icagen's North Carolina operations.As previously As a leader in ion channel drug discovery, OmniAb has deep experience in advancing ion channel drug discovery programs alone and in collaboration with pharmaceutical and biotech partners. The Icagen Ion Channel Technology platform allows progression of challenging ion channel targets by combining novel reagent generation, advanced biophysical analysis and cutting-edge applications of in silico The Board of Directors of Icagen has recommended that Icagen stockholders tender their shares into the tender offer. Questions and requests for assistance regarding the tender offer may be directed to the Information Agent for the offer, Morrow & Co., LLC at (800) 276-3011 or (203) 658-9400. |lfa| qug| rzi| yoz| mir| htd| blq| jqe| xoj| ung| skw| bit| xlk| khe| wql| dqo| dio| pts| mem| jqa| daq| xpp| xqd| eva| kjc| xdn| aku| xai| hpx| ohr| zko| xtw| mhm| qyb| czt| odr| tyt| uua| uiv| shw| lmo| ogc| ctq| xzw| ftw| gen| jpj| mww| axh| tkv|